Paul J. Hastings
Chief Executive Officer at Nkarta Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Nkarta Inc., 3 years.
Nkarta Inc.
Director · Chief Executive Officer
Pacira BioSciences Inc.
Director
enGene Therapeutics Inc.
Director
Chief executive roles
Nkarta Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2025 | Nkarta Inc. | Open-market sale | −1,790 | $1.79 | $3,204 |
| Jan 15, 2025 | Nkarta Inc. | Open-market sale | −17,378 | $2.20 | $38,232 |
| Jan 3, 2025 | Nkarta Inc. | Grant or award | +94,500 | — | — |
| Jun 18, 2024 | Nkarta Inc. | Open-market sale | −1,770 | $5.60 | $9,912 |
| Jun 13, 2024 | Pacira BioSciences Inc. | Open-market sale | −880 | $28.38 | $24,974 |
| Jun 12, 2024 | Pacira BioSciences Inc. | Grant or award | +5,230 | — | — |
| Mar 4, 2024 | Nkarta Inc. | Sold back to the company | −137,642 | $13.33 | $1,834,768 |
| Mar 1, 2024 | Nkarta Inc. | Sold back to the company | −12,358 | $13.00 | $160,654 |
| Jan 16, 2024 | Nkarta Inc. | Open-market sale | −9,697 | $8.74 | $84,752 |
| Jan 4, 2024 | Nkarta Inc. | Grant or award | +85,000 | — | — |
| Jun 20, 2023 | Nkarta Inc. | Open-market sale | −1,704 | $4.85 | $8,264 |
| Jun 14, 2023 | Pacira BioSciences Inc. | Grant or award | +1,775 | — | — |
| Jun 5, 2023 | Pacira BioSciences Inc. | Open-market sale | −580 | $38.34 | $22,237 |
| May 15, 2023 | Pacira BioSciences Inc. | Option exercise | +7,000 | $29.90 | $209,300 |
| May 15, 2023 | Pacira BioSciences Inc. | Open-market sale | −7,000 | $41.85 | $292,950 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.